Correlates and subgroups of injecting drug use in UK gay and bisexual men: Findings from the 2014 Gay Men’s Sex Survey

•Patterns of drug injecting in UK gay and bisexual men are poorly understood.•We examined correlates and subgroups of injecting drug use among GBM.•HIV positive, middle-aged, or London-resident GBM most often reported injecting.•GBM with sexual risk with multiple partners were most likely to report...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug and alcohol dependence 2018-06, Vol.187, p.292-295
Hauptverfasser: Melendez-Torres, G.J., Bourne, Adam, Hickson, Ford, Reid, David, Weatherburn, Peter
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Patterns of drug injecting in UK gay and bisexual men are poorly understood.•We examined correlates and subgroups of injecting drug use among GBM.•HIV positive, middle-aged, or London-resident GBM most often reported injecting.•GBM with sexual risk with multiple partners were most likely to report injecting.•We found evidence for three types of injection drug use (chemsex, opiate, eclectic). Evidence to understand which gay and bisexual men (GBM) inject drugs remains scant, especially in the UK. We describe correlates of last-year injecting in UK GBM, and characterise subgroups of GBM who inject drugs by types of drugs used. Using data from the 2014 Gay Men’s Sex Survey, an opportunistic internet-based survey conducted of GBM living in the UK, we examined via logistic regression correlates with any injecting of six drugs (amphetamine/speed, crystal methamphetamine, heroin, mephedrone, GHB/GBL, and ketamine) in the last year. We estimated latent class models to understand underlying subgroups of injecting drug use among GBM reporting injecting drug use in the last year. Injecting was most common in GBM who were of middle age, who were HIV seropositive, and who lived in London, and was significantly associated with sexual risk with multiple partners in the last year, whether steady or non-steady. Most GBM who engaged in injecting either injected crystal methamphetamine, mephedrone or both (class 1, chemsex, 88.6% of injectors), whereas a smaller group had a focus on opiates (class 2, opiate, 7.9%). A small but identifiable subgroup (class 3, eclectic, 3.5%) engaged in injecting across the range of drugs examined. This is the first epidemiological analysis to describe subgroups of injecting, and to describe correlates of injecting drug use, in UK GBM. Implications for design of harm reduction services include a need to focus on injecting drug use beyond opiates, currently the focus of most harm reduction services.
ISSN:0376-8716
1879-0046
DOI:10.1016/j.drugalcdep.2018.03.014